These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 37521222)

  • 21. A Notorious Trio! Inflammation, Metabolic Syndrome and Vitiligo.
    Mustafa AI; Hamed AM; Kadah AS; Fawzy EM; El Shimi OS
    Indian Dermatol Online J; 2023; 14(4):493-499. PubMed ID: 37521222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review.
    Qi F; Liu F; Gao L
    Front Immunol; 2021; 12():790125. PubMed ID: 34868078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid Risk Factors in Vitiligo: Homocysteine the Connecting Link?
    Taneja K; Taneja J; Kaur C; Patel S; Haldar D
    Clin Lab; 2020 Oct; 66(10):. PubMed ID: 33073941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum Levels of Hypersensitive-C-Reactive Protein in Vitiligo.
    Namazi MR; Nozari F; Ghoreyshi H
    Indian Dermatol Online J; 2018; 9(1):53-54. PubMed ID: 29441301
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of vaspin in the development of metabolic and glucose tolerance disorders and atherosclerosis.
    Dimova R; Tankova T
    Biomed Res Int; 2015; 2015():823481. PubMed ID: 25945347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highlights in pathogenesis of vitiligo.
    Mohammed GF; Gomaa AH; Al-Dhubaibi MS
    World J Clin Cases; 2015 Mar; 3(3):221-30. PubMed ID: 25789295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases.
    Furuhashi M; Saitoh S; Shimamoto K; Miura T
    Clin Med Insights Cardiol; 2014; 8(Suppl 3):23-33. PubMed ID: 25674026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated plasma YKL-40, lipids and lipoproteins, and ischemic vascular disease in the general population.
    Kjaergaard AD; Johansen JS; Bojesen SE; Nordestgaard BG
    Stroke; 2015 Feb; 46(2):329-35. PubMed ID: 25624368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitiligo Area Scoring Index and Vitiligo European Task Force assessment: reliable and responsive instruments to measure the degree of depigmentation in vitiligo.
    Komen L; da Graça V; Wolkerstorfer A; de Rie MA; Terwee CB; van der Veen JP
    Br J Dermatol; 2015 Feb; 172(2):437-43. PubMed ID: 25278165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The oxidase activity of vascular adhesion protein-1 (VAP-1) is essential for function.
    Noonan T; Lukas S; Peet GW; Pelletier J; Panzenbeck M; Hanidu A; Mazurek S; Wasti R; Rybina I; Roma T; Kronkaitis A; Shoultz A; Souza D; Jiang H; Nabozny G; Modis LK
    Am J Clin Exp Immunol; 2013; 2(2):172-85. PubMed ID: 23885334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome in vitiligo.
    Pietrzak A; Bartosińska J; Hercogová J; Lotti TM; Chodorowska G
    Dermatol Ther; 2012; 25 Suppl 1():S41-3. PubMed ID: 23237037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?
    Kralisch S; Fasshauer M
    Diabetologia; 2013 Jan; 56(1):10-21. PubMed ID: 23052058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The skin function: a factor of anti-metabolic syndrome.
    Zhou SS; Li D; Zhou YM; Cao JM
    Diabetol Metab Syndr; 2012 Apr; 4(1):15. PubMed ID: 22537765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients with vitiligo present fewer cardiovascular risk factors: results from a case-control study.
    Rodríguez-Martín M; de Paz NM; Mehtani P; Ferrer PC; Eliche MP; Martín BR; Sáez M; García M; Noda A
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):124-5. PubMed ID: 22176574
    [No Abstract]   [Full Text] [Related]  

  • 35. Vaspin prevents TNF-α-induced intracellular adhesion molecule-1 via inhibiting reactive oxygen species-dependent NF-κB and PKCθ activation in cultured rat vascular smooth muscle cells.
    Phalitakul S; Okada M; Hara Y; Yamawaki H
    Pharmacol Res; 2011 Nov; 64(5):493-500. PubMed ID: 21683791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin resistance is increased in patients with vitiligo.
    Karadag AS; Tutal E; Ertugrul DT
    Acta Derm Venereol; 2011 Sep; 91(5):541-4. PubMed ID: 21597678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melanin and melanogenesis in adipose tissue: possible mechanisms for abating oxidative stress and inflammation?
    Page S; Chandhoke V; Baranova A
    Obes Rev; 2011 May; 12(5):e21-31. PubMed ID: 20576005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke.
    Jimenez-Conde J; Biffi A; Rahman R; Kanakis A; Butler C; Sonni S; Massasa E; Cloonan L; Gilson A; Capozzo K; Cortellini L; Ois A; Cuadrado-Godia E; Rodriguez-Campello A; Furie KL; Roquer J; Rosand J; Rost NS
    Stroke; 2010 Mar; 41(3):437-42. PubMed ID: 20133919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SSAO/VAP-1 protein expression during mouse embryonic development.
    Valente T; Solé M; Unzeta M
    Dev Dyn; 2008 Sep; 237(9):2585-93. PubMed ID: 18729210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study.
    Ilanne-Parikka P; Eriksson JG; Lindström J; Peltonen M; Aunola S; Hämäläinen H; Keinänen-Kiukaanniemi S; Laakso M; Valle TT; Lahtela J; Uusitupa M; Tuomilehto J;
    Diabetes Care; 2008 Apr; 31(4):805-7. PubMed ID: 18184907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.